Please login to the form below

Not currently logged in
Email:
Password:

Cancer Drugs Fund

This page shows the latest Cancer Drugs Fund news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices

Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices

NICE recommended Darzalex in March this year via the Cancer Drugs Fund (CDF) for use as a monotherapy in relapsed and refractory myeloma in patients who have had three previous treatments. ... Pfizer responded by saying that the list prices of just 10%

Latest news

More from news
Approximately 48 fully matching, plus 104 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare

    A very notable victory has just been announced, with Keytruda becoming the first of the groundbreaking immunotherapy drugs to exit the Cancer Drugs Fund and secure NICE approval for first-line ... pharma’to become chief executive of Redx, a promising

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Companies have seen repeated attempts by the Government and NHS England to prevent patients from accessing new medicines, from the controversial reforms to the Cancer Drugs Fund to the ‘run

  • Opening up market access Opening up market access

    In this PME market access supplement we look at the direction of travel in France and Germany and there’ s an introduction to the UK’ s new-look Cancer Drugs Fund.

  • Opening up market access Opening up market access

    In this PME market access supplement we look at the direction of travel in France and Germany and there’ s an introduction to the UK’ s new-look Cancer Drugs Fund.

  • Stepping up to payer-driven market access Stepping up to payer-driven market access

    products. In the UK, for instance, NICE now regulates access to the Cancer Drugs Fund, and products will need to meet NICE thresholds in order to be reimbursed.

More from intelligence
Approximately 2 fully matching, plus 14 partially matching documents found.

Latest appointments

  • New health ministers and re-appointments after reshuffle New health ministers and re-appointments after reshuffle

    Freeman's role is also tied into the Department for Business, Innovation and Skills and includes expanded responsibility for the Cancer Drugs Fund, NICE and MHRA, research and development, issues around ... the uptake of new drugs and med tech, and the

  • Celgene names general manager for UK and Ireland Celgene names general manager for UK and Ireland

    This is even more pertinent with the recent changes to the Cancer Drugs Fund, which I strongly hope will enable patients with myeloma and metastatic pancreatic cancer to continue to be

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics